Sun Pharma share price closes at ₹1,865, up 1.01% on September 23

Key Takeaways:

• Sun Pharma’s ₹1,865 closing price for September 23 was confirmed by 5paisa’s refreshed 4:09 PM stock-page data. 
• The close was ₹28.10 below the 50-day DMA but ₹39.90 above the 200-day DMA, with the 100-day average at ₹1,871.60. 
• One-year return stood at 13.44%, while the six-month figure was 4.95% and one-month performance remained negative at -1.97%. 

Sun Pharmaceutical Industries share price ended September 23 at ₹1,865. The final price was confirmed on the individual 5paisa page in its refreshed post-close information at 4:09 PM. With the displayed prior close at ₹1,846, the page showed a daily increase of ₹18.60 or 1.01%. 

Sun Pharma’s market capitalisation stood at ₹4,47,476 crore. The 52-week range ran from approximately ₹1,548 at the lower end to ₹2,046.90 at the high, based on the refreshed annual-range information. The closing price was therefore ₹317 above the rounded annual low and ₹181.90 below the more precise 52-week high. 

The moving averages sat on both sides of the final price. Its 50-day DMA was ₹1,893.10, leaving the close ₹28.10 below that level. The 100-day DMA stood at ₹1,871.60, just ₹6.60 above the close. Sun Pharma’s 200-day DMA was ₹1,825.10, putting the final price ₹39.90 above the longer average. 

Return data also differed by horizon. One-month performance stood at -1.97%. The three-month return was narrowly positive at 0.11%, while the six-month figure reached 4.95%. Over one year, the return was 13.44%. 

The primary session header on the page continued to carry an earlier timestamp even after the post-close FAQ refreshed. For that reason, this article uses the final ₹1,865 close, market capitalisation, annual range, moving averages and return statistics that could be supported without treating the earlier intraday snapshot as a final session record. Intraday high, low and volume are deliberately excluded rather than carrying potentially stale session fields into the September 23 article.